News Oligomerix Receives Ongoing Support from NIH and Moves Forward with IND-enabling Studies June 3, 2019 By vera This article is sourced from an external publication. Read the original → ← PreviousOligomerix to Participate in the NIH Innovation Zone at 2019 BIO International ConventionNext →Oligomerix Awarded $2.18 Million SBIR Grant for Tau Oligomer Inhibitor for Alzheimer’s Disease and Related Disorders
